Gibbons v. GlaxoSmithKline, LLC et al
| Nathan Gibbons |
| Boehringer Ingelheim Pharmaceuticals Inc., GlaxoSmithKline LLC, Safeway Inc., Sanofi US Services Inc., Boehringer Ingelheim USA Corporation, Inc., Safeway Health, Inc., Sanofi-Aventis U.S. LLC and Grocery Outlet |
| 9:2021cv80236 |
| February 2, 2021 |
| US District Court for the Southern District of Florida |
| Robin L Rosenberg |
| Personal Inj. Prod. Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 25, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 28 Transmittal Letter Sent with Order Remanding Case to: Superior Court for the State of California County of Alameda. State Court Case Number: 3:21-cv-00442 (mc) |
Filing 27
ORDER granting (2569, 2740 in case 9:20-md-02924-RLR) Plaintiffs' Motion to Remand Cases to California State Court. Signed by Judge Robin L. Rosenberg on 2/25/2021. Related Cases: 9:20-md-02924-RLR, 9:21-cv-80236-RLR. See attached document for full details. (mc)
|
|
Filing 26
ORDER OF CONSOLIDATION AND ADMINISTRATIVE CLOSE-OUT. Signed by Judge Robin L. Rosenberg on 2/16/2021. See attached document for full details. (mc)
|
| Filing 25 MDL Transfer In Case Receipt from Northern District of California. Case Number 3:21-cv-00442 with documents 1-22. Assigned FLSD Case Number 9:21-cv-80236-RLR on 2/2/2021. Re: FLSD MDL Case Number 9:20-md-02924-RLR. (mc) |
| Filing 24 Clerks Notice of Judge Assignment to Judge Robin L. Rosenberg. (mc) |
| Filing 23 Case transferred in from California Northern; Case Number 3:21-cv-00442. Electronic file including transfer order and docket sheet received. .(mc). |
| Filing 22 CONDITIONAL TRANSFER ORDER (CTO-52) by MDL Panel TRANSFERRING CASE to the Southern District of Florida. (slhS, COURT STAFF) (Filed on 1/29/2021) |
| Filing 21 STIPULATION Stipulation to Extend Time to Answer or Otherwise Respond to Complaint filed by Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC. (Mayo, Sharon) (Filed on 1/29/2021) |
| Filing 20 Amended MOTION to Stay re #5 MOTION to Stay Proceedings Pending Transfer to the MDL filed by Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Inc., GlaxoSmithKline, LLC, Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC. Motion Hearing set for 2/26/2021 10:00 AM before Judge Susan Illston. Responses due by 2/2/2021. Replies due by 2/9/2021. (Attachments: #1 Proposed Order)(Tam, Jonathan) (Filed on 1/21/2021) |
| Filing 19 INITIAL CASE MANAGEMENT GUIDELINE AND CLERK'S NOTICE ON REASSIGNMENT. Initial Case Management Conference set for 4/23/2021 at 02:30 PM in San Francisco, Courtroom 01, 17th Floor. Joint Case Management Statement due by 4/16/2021. (ecS, COURT STAFF) (Filed on 1/21/2021) |
|
Filing 18
ORDER REASSIGNING CASE. Case reassigned to Judge Susan Illston for all further proceedings. Magistrate Judge Donna M. Ryu no longer assigned to case, Notice: The assigned judge participates in the Cameras in the Courtroom Pilot Project. See General Order No. 65 and http://cand.uscourts.gov/cameras.Signed by the Clerk on 1/21/2021. (Attachments: #1 Notice of Eligibility for Video Recording)(anjS, COURT STAFF) (Filed on 1/21/2021)
|
|
Filing 17
AMENDED ORDER RELATING CASE. Signed by Judge Susan Illston on 1/20/2021. (ecS, COURT STAFF) (Filed on 1/20/2021)
|
| Filing 15 CLERK'S NOTICE Re: Consent or Declination: Plaintiff and Defendants shall file a consent or declination to proceed before a magistrate judge. Note that any party is free to withhold consent to proceed before a magistrate judge without adverse substantive consequences. The forms are available at: http://cand.uscourts.gov/civilforms. Consent/Declination due by 1/27/2021. (ig, COURT STAFF) (Filed on 1/20/2021) |
| Filing 14 Rule 7.1 Disclosures by GlaxoSmithKline, LLC identifying Corporate Parent Glaxo Smithkline, plc for GlaxoSmithKline, LLC. (Tam, Jonathan) (Filed on 1/20/2021) |
| Filing 13 Corporate Disclosure Statement by Sanofi-Aventis U.S. LLC identifying Corporate Parent Sanofi for Sanofi-Aventis U.S. LLC. (Mayo, Sharon) (Filed on 1/20/2021) |
| Filing 12 Corporate Disclosure Statement by Sanofi US Services, Inc. identifying Corporate Parent Sanofi for Sanofi US Services, Inc.. (Mayo, Sharon) (Filed on 1/20/2021) |
| Filing 11 NOTICE of Appearance by Tommy Huynh (Huynh, Tommy) (Filed on 1/20/2021) |
| Filing 10 CERTIFICATE OF SERVICE by Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Inc. re #9 Notice (Other), #8 Certificate of Interested Entities, #7 Notice of Appearance (Blaschke, Matthew) (Filed on 1/20/2021) |
| Filing 9 NOTICE of Defendants' Administrative Motion to Consider Whether Cases Should be Related Pursuant to Civil L.R. 3-12 by Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Inc., GlaxoSmithKline, LLC, Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC (Attachments: #1 Exhibit 1 - Defendants' Administrative Motion to Consider Whether Cases Should Be Related)(Blaschke, Matthew) (Filed on 1/20/2021) Modified on 1/20/2021 (jmlS, COURT STAFF). |
| Filing 8 Rule 7.1 Disclosures by Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Inc. identifying Corporate Parent Boehringer Ingelheim Corporation, Corporate Parent Boehringer Ingelheim USA Corporation for Boehringer Ingelheim Pharmaceuticals, Inc.. (Blaschke, Matthew) (Filed on 1/20/2021) |
| Filing 7 NOTICE of Appearance by Matthew J. Blaschke (Blaschke, Matthew) (Filed on 1/20/2021) |
| Filing 6 Initial Case Management Scheduling Order with ADR Deadlines: Case Management Statement due by 4/14/2021. Initial Case Management Conference set for 4/21/2021 01:30 PM in Oakland, Courtroom 4, 3rd Floor. (jmlS, COURT STAFF) (Filed on 1/20/2021) |
| #Electronic filing error. NOTICE TO COUNSEL: Matthew J. Blaschke. The docket shows a different address from what is appearing on the document (dkt. #: 7 Notice of Appearance filed by Boehringer Ingelheim USA Corporation, Inc., Boehringer Ingelheim Pharmaceuticals, Inc.). Please update your personal profile on ECF. (jmlS, COURT STAFF) (Filed on 1/20/2021) |
| #Electronic filing error. No title Page. Certificates/Proofs of Service e-filed separately and not as an attachment, require a title page. Please refer to Civil Local Rules 3-4 re first page requirement. Re: #10 Certificate of Service, filed by Boehringer Ingelheim USA Corporation, Inc., Boehringer Ingelheim Pharmaceuticals, Inc. (jmlS, COURT STAFF) (Filed on 1/20/2021) |
| #Electronic filing error. Judge initials are missing. Counsel need not re-file the document, but should reference the correct judge initials (DMR)on future filings. Re: #10 Certif icate of Service, filed by Boehringer Ingelheim USA Corporation, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., #15 Clerk's Notice re: Consent or Declination, #11 Notice of Appearance filed by Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC, #12 Certificate of Interested Entities filed by Sanofi US Services, Inc., #8 Certificate of Interested Entities, filed by Boehringer Ingelheim USA Corporation, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., #7 Notice of Appearance filed by Boehringer Ingelheim USA Corporation, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., #13 Certificate of Interested Entities filed by Sanofi-Aventis U.S. LLC, #14 Certificate of Interested Entities filed by GlaxoSmithKline, LLC, #9 Notice (Other), filed by Sanofi US Services, Inc., GlaxoSmithKline, LLC, Boehringer Ingelheim USA Corporation, Inc., Sanofi-Aventis U.S. LLC, Boehringer Ingelheim Pharmaceuticals, Inc. (jmlS, COURT STAFF) (Filed on 1/20/2021) |
| Filing 5 MOTION to Stay Proceedings Pending Transfer to the MDL filed by Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Inc., GlaxoSmithKline, LLC, Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC. Motion Hearing set for 2/25/2021 01:00 PM before Magistrate Judge Donna M. Ryu. Responses due by 2/2/2021. Replies due by 2/9/2021. (Attachments: #1 Proposed Order)(Tam, Jonathan) (Filed on 1/19/2021) |
| Filing 4 NOTICE of Appearance by Jonathan S. Tam for GlaxoSmithKline LLC (Tam, Jonathan) (Filed on 1/19/2021) |
| Filing 3 CERTIFICATE OF SERVICE by Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC re #1 Notice of Removal, (Podsiadlo, Kathryn) (Filed on 1/19/2021) |
| Filing 2 Case assigned to Magistrate Judge Donna M. Ryu. Counsel for plaintiff or the removing party is responsible for serving the Complaint or Notice of Removal, Summons and the assigned judge's standing orders and all other new case documents upon the opposing parties. For information, visit E-Filing A New Civil Case at http://cand.uscourts.gov/ecf/caseopening.Standing orders can be downloaded from the court's web page at www.cand.uscourts.gov/judges. Upon receipt, the summons will be issued and returned electronically. Counsel is required to send chambers a copy of the initiating documents pursuant to L.R. 5-1(e)(7). A scheduling order will be sent by Notice of Electronic Filing (NEF) within two business days. Consent/Declination due by 2/2/2021. (anjS, COURT STAFF) (Filed on 1/19/2021) |
| Filing 1 NOTICE OF REMOVAL from Alameda County Superior Court. Their case number is HG20084493 with jury demand (no process). (Filing fee $402 receipt number 0971-15458946). Filed by Sanofi-Aventis U.S. LLC, Sanofi US Services, Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(Mayo, Sharon) (Filed on 1/19/2021) Modified on 1/20/2021 (jmlS, COURT STAFF). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
